OrbiMed’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.01M | Sell |
313,200
-34,800
| -10% | -$223K | 0.05% | 84 |
|
2025
Q1 | $1.23M | Hold |
348,000
| – | – | 0.03% | 96 |
|
2024
Q4 | $1.32M | Buy |
+348,000
| New | +$1.32M | 0.03% | 101 |
|
2023
Q2 | – | Sell |
-813,500
| Closed | -$23.9M | – | 120 |
|
2023
Q1 | $23.9M | Buy |
+813,500
| New | +$23.9M | 0.47% | 60 |
|